DeepUll Stock

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

Sign up today and learn more about DeepUll Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About DeepUll Stock

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.

Funding History

July 2020$3.5M
October 2022$13.0M
December 2022$20.0M
March 2023$17.0M

Management

Co-Founder & Chief Executive Officer

Jordi Carrera

Board member

Josep L.l. Sanfeliu

Co-Founder & Chief Technology Officer

Rafel Bru

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo